[Federal Register Volume 84, Number 171 (Wednesday, September 4, 2019)]
[Notices]
[Pages 46549-46550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-19201]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health, Office of 
Infectious Disease Policy.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that a 
meeting is scheduled to be held for the National Vaccine Advisory 
Committee (NVAC). The meeting will be open to the public; public 
comment sessions will be held during the meeting.

DATES: The meeting will be held on September 17 and 18, 2019. The 
meeting times and agenda will be posted on the NVAC website at https://www.hhs.gov/vaccines/nvac/meetings/index.html as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, The Great Hall, 200 Independence Avenue SW, 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast on both 
days of the meeting. For more information, visit https://www.hhs.gov/webforms/nvac/index.html.
    Pre-registration is required for members of the public who wish to 
attend the meeting and who wish to participate in a public comment 
session. Individuals who wish to attend the meeting and/or participate 
in a public comment session should register at https://www.hhs.gov/webforms/nvac/index.html. Participants may also register by emailing 
[email protected] or by calling (202) 795-7697 and providing their name, 
organization, and email address.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, Office of Infectious Disease Policy, U.S. Department of Health 
and Human Services, Room L001, Switzer Building, 330 C Street SW, 
Washington, DC 20201. Phone: (202) 795-7697; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve

[[Page 46550]]

optimal prevention against adverse reactions to vaccines. The NVAC was 
established to provide advice and make recommendations to the Director 
of the National Vaccine Program on matters related to the Program's 
responsibilities. The Assistant Secretary for Health serves as Director 
of the National Vaccine Program.
    During the September 2019 NVAC meeting, sessions will consist of 
presentations on immunization equity, immunity, vaccines for small 
populations and uncommon diseases, and influenza safety monitoring, and 
evidence-based tools for improving influenza vaccination efforts. 
Please note that agenda items will be related to the charges of the 
Committee and are subject to change as priorities dictate. Information 
on the final meeting agenda will be posted prior to the meeting on the 
NVAC website: https://www.hhs.gov/vaccines/nvac/meetings/index.html.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend in person and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the Office of Infectious Disease Policy 
at the address/phone number listed above at least one week prior to the 
meeting. For those unable to attend in person, a live webcast will be 
available. More information on registration and accessing the webcast 
can be found at https://www.hhs.gov/vaccines/nvac/meetings/index.html.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the Office of Infectious Disease Policy ([email protected]) at least five 
business days prior to the meeting.

    Dated: August 16, 2019.
Ann Aikin,
Acting Designated Federal Officer, Office of Infectious Disease and 
HIV/AIDS Policy.
[FR Doc. 2019-19201 Filed 9-3-19; 8:45 am]
BILLING CODE 4150-44-P